Evidence map›Paper›PMID 11975418›Full record

ReviewClinical reviews in allergy & immunology2002

Mast cell growth, differentiation, and death.

Michael F Gurish, Joshua A Boyce

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical reviews in allergy & immunology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Mast cells promote small bowel cancer in a tumor stage-specific and cytokine-dependent manner.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  9. Article
  10. The role of mast cells in oral squamous cell carcinoma.Contemporary oncology (Poznan, Poland) · 2017
    Review
  11. Pros and Cons of Clinical Basophil Testing (BAT).Current allergy and asthma reports · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Hematopoietic stem/precursor cells as HIV reservoirs.Current opinion in HIV and AIDS · 2011
    Review
  18. Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma.International journal of clinical and experimental pathology · 2010
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Michael F GurishDepartment of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, USA.
Joshua A Boyce
Brigham and Women's Hospital · USHarvard University · US

Funding

Role of PGE2 in Human Mast Cell BiologyP01HL036110 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LAM, BING K · 1985 to 2009
$20.1M
DISRUPTION AND EXPRESSION OF MAST CELL PROTEASE GENESR01HL063284 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI STEVENS, RICHARD L · 1999 to 2002
$1.1M
URINARY AND EXCRETION OF LTR AS AN INDEX OF AIRWAY RESPONSESU01AI031599 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI STEVENS, RICHARD L · 1991 to 1994
–
THE V3 MASTOCYTOSIS MOUSE--MAST CELL DIFFERENTIATION, MATURATION, AND FUNCTIONU19AI031599 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI AUSTEN, K. FRANK · 1995 to 1998
–
NHLBI NIH HHS HL 36110-16NHLBI NIH HHS HL 63284-02NIAID NIH HHS AI 31599-10
6 · The paper itself

Abstract

Mast cells (MC) begin development in the bone marrow. Following initial lineage commitment, the cells move into the vasculature as a committed progenitor (MCp) that is poorly phenotypically defined, but appears to be an agranular cell lacking the high-affinity IgE receptor characteristic of the mature tissue-localized MC. Full maturation occurs after the cells move into the various tissues. In the mouse, MCp localizing in the connective tissues appear to differentiate into mature MC, whereas those localizing in the lung and mucosal compartment of the small intestine remain largely as committed MCp. Movement of the MCp into the small intestine is controlled by the alpha 4 beta 7 integrin, whereas the factors controlling movement into other tissues remain to be defined. Following an inflammatory stimulus, Th2-derived cytokines drive the maturation process of these MCps, leading to the mature mucosal MC hyperplasia associated with events such as an intestinal helminth infection and possibly human allergy such as asthma and rhinitis. The expanded MC number disappears as the stimulus resolves. Various routes are used in the resolution of the MC hyperplasia including apoptosis, shedding along with the villous epithelium, and recirculation back to the spleen for elimination. Unlike the reactive MC that appears in association with inflammation, the connective tissue-localized MC is a long-lived radiation-resistant cell, which appears to depend principally on the presence of stem cell factor (SCF) for its persistence.

Indexed as

AnimalsCell DeathCell DifferentiationCell DivisionHumansMast CellsStem Cell FactorStem Cell Factor

Identifiers

PMID11975418
OpenAlexW2090442609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.